MY ACCOUNT | NEWSLETTER |

Innovative diagnostic strategies for equine habronemiasis: exploring molecular identification, gene expression, and oxidative stress markers


Background

Equine habronemiasis, caused by Habronema (H.) muscae, H. microstoma, and Draschia megastoma, is a parasitic disease that presents in both gastric and cutaneous forms. Conventional diagnostic methods often lack sensitivity due to intermittent egg shedding and nonspecific clinical signs. This study aimed to enhance diagnostic accuracy by integrating molecular identification, oxidative stress profiling, and cytokine gene expression analysis.

Methods

A total of 100 horses from a private farm in Giza, Egypt, were clinically examined for signs of habronemiasis. Fecal and skin samples were examined using parasitological techniques alongside polymerase chain reaction (PCR) targeting the mitochondrial cytochrome c oxidase subunit I (COXI) gene. The serum levels of oxidative stress biomarkers, including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH), and total antioxidant capacity (TAC), were quantified. Additionally, the expression of cytokines (interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), interleukin 1 beta (IL-1β) and interleukin-6 (IL-6))was assessed via real-time PCR.

Results

Habronema spp. eggs were detected in 62% of fecal samples, with molecular analysis confirming H. muscae as the predominant species. Infected horses exhibited significantly elevated oxidative stress markers compared with those in healthy controls. Cytokine gene expression analysis demonstrated a marked upregulation of proinflammatory markers, indicating a Th1-dominated immune response.

Conclusions

This study underscores the value of molecular diagnostics combined with immunological profiling for the detection and characterization of equine habronemiasis. The integration of oxidative stress and cytokine biomarkers provides important insights into host–pathogen interactions and may contribute to the development of improved diagnostic and therapeutic strategies.


Authors: Mai A. Salem, Sohila M. El-Gameel, Mohamed S. Kamel, Eslam M. Elsamman, Reem M. Ramadan

Source: https://link.springer.com/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Sudan Ebola virus can persist in survivors for months, WSU study shows

Like0
Dislike0

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Like0
Dislike0

Small-animal revolving funds: an innovative programming model to increase access to and consumption of animal-source foods by rural households in Malawi

Like0
Dislike0

Seroprevalence and Molecular detection of Toxoplasma gondii Infections in Rodents and Cats in Mbeya District, Tanzania.

Like0
Dislike0

Wound repair in the horse: Problems and proposed innovative solutions

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top